Importantly, pharmacological inhibition of LRH-1 was also able to significantly inhibit LPS-induced TNF production in vivo, thus preventing LPS/N-acetyl-d-galactosamine (GalN)-induced, TNF-mediated, acute hepatitis in mice. The gene discussed is NR5A2; the disease is Acute hepatitis.